FLT3 as a Marker of Minimal Residual Disease: Time to Re-Think?

American Journal of Hematology - United States
doi 10.1002/ajh.24667
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy